|
US6673779B2
(en)
*
|
1996-03-27 |
2004-01-06 |
Inspire Pharmaceuticals, Inc. |
Method of treating ciliary dyskinesia with dinucleoside polyphosphate compounds or UTP analogues
|
|
US6319908B1
(en)
|
1996-07-03 |
2001-11-20 |
Inspire Pharmaceuticals, Inc. |
Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
|
|
US5763447C1
(en)
|
1996-07-23 |
2002-05-07 |
Inspire Pharmaceuticals |
Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
|
|
EP0981534B1
(en)
|
1997-02-06 |
2006-05-03 |
Inspire Pharmaceuticals, Inc. |
Dinucleotides and their uses
|
|
US7078391B2
(en)
|
1997-02-10 |
2006-07-18 |
Inspire Pharmaceuticals, Inc. |
Method of treating edematous retinal disorders
|
|
US7223744B2
(en)
*
|
1997-02-10 |
2007-05-29 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
|
|
US6596725B2
(en)
*
|
1997-02-10 |
2003-07-22 |
Inspire Pharmaceuticals, Inc. |
Use of certain dinucleotides to stimulate removal of fluid in retinal detachment and retinal edema
|
|
US6818629B2
(en)
*
|
1997-02-10 |
2004-11-16 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
|
|
US6462028B2
(en)
|
1997-07-25 |
2002-10-08 |
Inspire Pharmaceuticals, Inc. |
Method of promoting cervical and vaginal secretions
|
|
TW593331B
(en)
|
1997-07-25 |
2004-06-21 |
Inspire Pharmaceuticals Inc |
Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
|
|
US6548658B2
(en)
*
|
1997-07-25 |
2003-04-15 |
Inspire Pharmaceuticals, Inc. |
Di-(uridine 5′)-tetraphosphate and salts thereof
|
|
US6872710B2
(en)
*
|
1997-07-25 |
2005-03-29 |
Inspire Pharmaceuticals, Inc. |
Di(uridine 5′)-tetraphosphate and salts thereof
|
|
CA2295515C
(en)
*
|
1997-07-25 |
2006-03-14 |
Inspire Pharmaceuticals, Inc. |
Method for large-scale production of di(uridine 5'-tetraphosphate) and salts thereof
|
|
BR9811612A
(pt)
*
|
1997-08-29 |
2000-08-08 |
Univ North Carolina |
Uso de 5' -difosfato de uridina e similares para tratamento de doenças pulmonares
|
|
DE69905464T2
(de)
*
|
1998-05-22 |
2004-01-15 |
Inspire Pharmaceuticals Inc |
Therapeutische dinucleotide und deren derivate
|
|
EP1140967A1
(en)
*
|
1998-12-23 |
2001-10-10 |
University Of North Carolina At Chapel Hill |
Targeted gene transfer using g protein coupled receptors
|
|
KR20010114214A
(ko)
|
1999-02-26 |
2001-12-31 |
인스파이어 파마슈티컬스 인코퍼레이티드 |
우리딘, 아데닌 및 시티딘 디포스페이트 및 그의 유사체에의한 점막수화 촉진방법
|
|
NZ516301A
(en)
*
|
1999-06-30 |
2003-07-25 |
Yamasa Corp |
Dinucleotide crystals
|
|
AU6551800A
(en)
*
|
1999-08-17 |
2001-03-13 |
Adani, Alexander |
Dinucleoside 5',5'-tetraphosphates as inhibitors of viral reverse transcriptasesand viruses
|
|
JP2003524636A
(ja)
*
|
1999-12-22 |
2003-08-19 |
インスパイアー ファーマシューティカルズ,インコーポレイティド |
プリン性受容体アゴニストによる胃腸管の処置方法
|
|
RU2161982C1
(ru)
*
|
2000-01-20 |
2001-01-20 |
Общество с ограниченной ответственностью "Клиника Института биорегуляции и геронтологии" |
Тетрапептид, стимулирующий функцию сетчатой оболочки глаза, фармакологическое средство на его основе и способ его применения
|
|
US6864243B1
(en)
*
|
2000-05-12 |
2005-03-08 |
Inspire Pharmaceuticals, Inc. |
Method for treating retinal degeneration with purinergic receptor agonists
|
|
AU2001260643B9
(en)
|
2000-05-30 |
2006-10-19 |
Merck Sharp & Dohme Corp. |
Ectocornea extension promoters
|
|
US7115585B2
(en)
*
|
2000-08-21 |
2006-10-03 |
Inspire Pharmaceuticals, Inc. |
Compositions for treating epithelial and retinal tissue diseases
|
|
US7452870B2
(en)
|
2000-08-21 |
2008-11-18 |
Inspire Pharmaceuticals, Inc. |
Drug-eluting stents coated with P2Y12 receptor antagonist compound
|
|
US7018985B1
(en)
|
2000-08-21 |
2006-03-28 |
Inspire Pharmaceuticals, Inc. |
Composition and method for inhibiting platelet aggregation
|
|
US6867199B2
(en)
|
2000-08-21 |
2005-03-15 |
Inspire Pharmaceuticals, Inc. |
Dinucleoside polyphosphate compositions and their therapeutic use
|
|
US6555675B2
(en)
*
|
2000-08-21 |
2003-04-29 |
Inspire Pharmaceuticals, Inc. |
Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists
|
|
US7132408B2
(en)
*
|
2000-08-21 |
2006-11-07 |
Inspire Pharmaceuticals, Inc. |
Composition and method for inhibiting platelet aggregation
|
|
JP2005502580A
(ja)
*
|
2000-12-15 |
2005-01-27 |
フアーマセツト・リミテツド |
フラビウィルス感染治療用抗ウィルス薬
|
|
US20040122223A1
(en)
*
|
2001-02-07 |
2004-06-24 |
Davis Jeremy Martin |
Non-natural nucleotides and dinucleotides
|
|
WO2003000056A1
(en)
|
2001-06-25 |
2003-01-03 |
Inspire Pharmaceuticals, Inc. |
Joint lubrication with p2y purinergic receptor agonists
|
|
US20050009777A1
(en)
*
|
2001-07-25 |
2005-01-13 |
Mack Stephen Robert |
Non-natural carbon-linked nucleotides and dinucleotides
|
|
WO2003030892A1
(en)
*
|
2001-10-11 |
2003-04-17 |
Alcon, Inc. |
Methods for treating dry eye
|
|
MXPA04004215A
(es)
|
2001-11-06 |
2004-07-08 |
Inspire Pharmaceuticals Inc |
Metodo para el tratamiento o la prevencion de enfermedades inflamatorias.
|
|
US7084128B2
(en)
|
2002-01-18 |
2006-08-01 |
Inspire Pharmaceuticals, Inc. |
Method for reducing intraocular pressure
|
|
MXPA05004121A
(es)
*
|
2002-10-18 |
2006-02-17 |
Molichem Medicines Inc |
Metodos para tratar la enfermedad de ojo reseco con lantibioticos.
|
|
US6984628B2
(en)
*
|
2003-07-15 |
2006-01-10 |
Allergan, Inc. |
Ophthalmic compositions comprising trefoil factor family peptides
|
|
WO2005107787A1
(en)
*
|
2004-05-06 |
2005-11-17 |
Molichem Medicines, Inc. |
Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
|
|
CA2565545A1
(en)
*
|
2004-05-06 |
2005-12-08 |
Molichem Medicines, Inc. |
Treatment of ocular diseases and disorders using lantibiotic compositions
|
|
GB0417886D0
(en)
*
|
2004-08-11 |
2004-09-15 |
Univ Cardiff |
Method and means for enhanced pulmonary delivery
|
|
GB0502250D0
(en)
*
|
2005-02-03 |
2005-03-09 |
Ic Vec Ltd |
Use
|
|
US7368439B2
(en)
*
|
2005-06-15 |
2008-05-06 |
Bar - Ilan University |
Dinucleoside poly(borano)phosphate derivatives and uses thereof
|
|
US7851456B2
(en)
*
|
2005-06-29 |
2010-12-14 |
Inspire Pharmaceuticals, Inc. |
P2Y6 receptor agonists for treating lung diseases
|
|
EP2036567A3
(en)
|
2005-12-06 |
2009-12-09 |
P2-Science APS |
Modulation of the P2Y2 receptor pathway
|
|
US20070249556A1
(en)
*
|
2006-04-21 |
2007-10-25 |
Brubaker Kurt E |
Method of treating inflammation
|
|
WO2008012949A1
(en)
*
|
2006-07-26 |
2008-01-31 |
Yamasa Corporation |
Process for producing di(pyrimidine nucleoside 5'-)polyphosphate
|
|
EP2049665A2
(en)
*
|
2006-07-28 |
2009-04-22 |
Applera Corporation |
Dinucleotide mrna cap analogs
|
|
WO2009049159A1
(en)
|
2007-10-10 |
2009-04-16 |
Parion Sciences, Inc. |
Delivering osmolytes by nasal cannula
|
|
US8168597B2
(en)
*
|
2008-10-22 |
2012-05-01 |
Inspire Pharmaceuticals, Inc. |
Method for treating cystic fibrosis
|
|
US9067964B2
(en)
|
2008-12-18 |
2015-06-30 |
Oligomer Sciences Ab |
Complex and method for enhancing nuclear delivery
|
|
US9011909B2
(en)
|
2010-09-03 |
2015-04-21 |
Wisconsin Pharmacal Company, Llc |
Prebiotic suppositories
|
|
CA2810481C
(en)
*
|
2010-09-10 |
2018-06-19 |
Santen Pharmaceutical Co., Ltd. |
Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
|
|
EP2717855A4
(en)
|
2011-06-07 |
2014-11-12 |
Parion Sciences Inc |
Methods of Treatment
|
|
US8945605B2
(en)
|
2011-06-07 |
2015-02-03 |
Parion Sciences, Inc. |
Aerosol delivery systems, compositions and methods
|
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
|
MY169816A
(en)
|
2012-03-26 |
2019-05-16 |
Santen Pharmaceutical Co Ltd |
Ophthalmic solution comprising diquafosol
|
|
WO2013181232A2
(en)
|
2012-05-29 |
2013-12-05 |
Michael Ross Johnson |
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
|
|
RU2671976C2
(ru)
|
2012-12-17 |
2018-11-08 |
Пэрион Сайенсиз, Инк. |
Соединения 3,5-диамино-6-хлор-n-(n-(4-фенилбутил)карбамимидоил)пиразин-2-карбоксамида
|
|
ES2674665T3
(es)
|
2012-12-17 |
2018-07-03 |
Parion Sciences, Inc. |
Compuestos de 3,5-diamino-6-cloro-N-(N-(4-fenilbutilo)carbamimidoilo)-pirazina-2-carboxamida
|
|
HUE032891T2
(hu)
|
2012-12-17 |
2017-11-28 |
Parion Sciences Inc |
Klórpirazin-karboxamid-származékok nem kielégítõ nyálkahártya-hidratáció által elõsegített megbetegedések kezelésére
|
|
CA2956163C
(en)
|
2014-07-24 |
2023-01-10 |
W.R. Grace & Co.-Conn. |
Crystalline form of nicotinamide riboside
|
|
ES2963057T3
(es)
|
2015-03-09 |
2024-03-25 |
Grace W R & Co |
Forma cristalina de ribósido de nicotinamida
|
|
EP3297615A1
(en)
*
|
2015-05-20 |
2018-03-28 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Methods and pharmaceutical composition for modulation polarization and activation of macrophages
|
|
EP3727400A4
(en)
|
2017-12-22 |
2021-10-20 |
Elysium Health, Inc. |
CRYSTALLINE FORMS OF NICOTINAMIDE RIBOSIDE CHLORIDE
|
|
EP3919062A1
(en)
|
2020-06-02 |
2021-12-08 |
Institut Gustave-Roussy |
Modulators of purinergic receptors and related immune checkpoint for treating acute respiratory distress syndrom
|
|
US20230302031A1
(en)
|
2020-06-02 |
2023-09-28 |
Institut Gustave-Roussy |
Modulators Of Purinergic Receptors and Related Immune Checkpoint For Treating Acute Respiratory Distress Syndrome
|